APPRAISAL OF LONG-TERM LEVODOPA TREATMENT OF PARKINSONISM WITH SPECIAL REFERENCE TO THERAPY LIMITING FACTORS

被引:0
|
作者
PRESTHUS, J [1 ]
HOLMSEN, R [1 ]
机构
[1] UNIV OSLO,ULLEVAL HOSP,DEPT NEUROLOGY,OSLO,NORWAY
来源
ACTA NEUROLOGICA SCANDINAVICA | 1974年 / 50卷 / 06期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:774 / 790
页数:17
相关论文
共 50 条
  • [21] LONG-TERM ASSESSMENT OF LEVODOPA THERAPY IN PARKINSON DISEASE
    BARBEAU, A
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1975, 112 (12) : 1379 - 1380
  • [22] LONG-TERM EXPERIENCE WITH PERGOLIDE THERAPY OF ADVANCED PARKINSONISM
    KURLAN, R
    MILLER, C
    LEVY, R
    MACIK, B
    HAMILL, R
    SHOULSON, I
    NEUROLOGY, 1985, 35 (05) : 738 - 742
  • [23] Long-term outcome of cap polyposis, with special reference to the effects of steroid therapy
    Chang, Hye-Sook
    Yang, Suk-Kyun
    Kim, Mi-Jung
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Kim, Jin-Ho
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (01) : 211 - 216
  • [24] LONG-TERM TREATMENT OF PARKINSONS-DISEASE WITH LEVODOPA
    MARTIN, WE
    LOEWENSON, RB
    BILEK, MK
    RESCH, JA
    BAKER, AB
    JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2): : 77 - 93
  • [25] Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test
    Acharya, Mrinal
    Banerjee, Subhadeep
    Chatterjee, Apratim
    Mukherjee, Adreesh
    Biswas, Samar
    Gangopadhyay, Goutam
    Biswas, Atanu
    NEUROLOGY INDIA, 2021, 69 (02) : 430 - 434
  • [26] LONG-TERM TREATMENT OF PARKINSONISM WITH L-DOPA
    PRESTHUS, J
    HOLMSEN, R
    ACTA NEUROLOGICA SCANDINAVICA, 1972, 48 : 131 - &
  • [27] MESULERGINE AND BROMOCRIPTINE IN LONG-TERM TREATMENT OF ADVANCED PARKINSONISM
    BAAS, H
    SCHNEIDER, E
    FISCHER, PA
    JAPP, G
    JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (01) : 45 - 54
  • [28] PARKINSONS-DISEASE - LONG-TERM RESULTS OF LEVODOPA THERAPY
    PENTLAND, B
    MATTHEWS, D
    MAWDSLEY, C
    SCOTTISH MEDICAL JOURNAL, 1982, 27 (04) : 284 - 287
  • [29] DECREASING DYSKINESIAS WITH LONG-TERM LEVODOPA-BROMOCRIPTINE THERAPY
    GRIMES, JD
    HASSAN, MN
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 196 - 197
  • [30] SAFETY OF LONG-TERM LEVODOPA THERAPY IN MALIGNANT-MELANOMA
    WOOFTER, MJA
    MANYAM, BV
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (04) : 315 - 319